Akanda Corp. (NASDAQ:AKAN – Get Free Report) was the recipient of a significant decline in short interest in February. As of February 27th, there was short interest totaling 25,178 shares, a decline of 55.7% from the February 12th total of 56,789 shares. Based on an average daily trading volume, of 85,737 shares, the short-interest ratio is presently 0.3 days. Approximately 1.3% of the shares of the company are short sold. Approximately 1.3% of the shares of the company are short sold. Based on an average daily trading volume, of 85,737 shares, the short-interest ratio is presently 0.3 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings restated a “sell (e+)” rating on shares of Akanda in a research note on Monday, January 12th. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.
View Our Latest Analysis on AKAN
Akanda Trading Down 2.9%
About Akanda
Akanda Corp., through its subsidiaries, engages in the cultivation, manufacture, and distribution of cannabis products to patients worldwide. It offers medicinal-grade cannabis and cannabis based medical and wellness products. The company was incorporated in 2021 and is headquartered in New Romney, the United Kingdom.
Featured Stories
- Five stocks we like better than Akanda
- A personal warning from Martin Weiss (Please read)
- SpaceX IPO Confirmed: Claim Your Stake Today
- This coin has everything going for it
- Only 500 people today…
- The gold chart Wall Street is terrified of…
Receive News & Ratings for Akanda Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Akanda and related companies with MarketBeat.com's FREE daily email newsletter.
